CAMLIN FINE SCIENCES LTD (CAMLINFINE) financials
CAMLIN FINE SCIENCES LTD (CAMLINFINE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
- Market Cap: ₹1,546Cr.
- Current Price: ₹80.4
- ROE: -1.72%
- ROCE: 2.86%
- Book Value: ₹48.4
- Dividend Yield: 0.00%
- 52W High / Low: ₹203/78.8
In Jun 2026, CAMLIN FINE SCIENCES LTD (CAMLINFINE) reported sales ₹222 Cr and net profit ₹-12 Cr.
Annual TTM: sales ₹869 Cr, net profit ₹-35 Cr.
Shareholding: Promoters 48.03% (Sep 2026), FIIs 0.94% (Sep 2026), DIIs 5.33% (Sep 2026), Public 45.69% (Sep 2026), No. of Shareholders 56,981% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 227 | 205 | 273 | 191 | 244 | 219 | 184 | 222 |
| Expenses | 213 | 189 | 239 | 187 | 226 | 200 | 178 | 216 |
| Operating Profit | 14 | 16 | 33 | 5 | 18 | 19 | 6 | 7 |
| OPM % | 6% | 8% | 12% | 2.4% | 7% | 9% | 3.3% | 3.1% |
| Other Income | -93 | 7 | 9 | 4 | 10 | -8 | 13 | 1 |
| Interest | 18 | 17 | 17 | 11 | 19 | 15 | 22 | 13 |
| Depreciation | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 |
| Profit before tax | -111 | -7 | 12 | -16 | -4 | -17 | -17 | -19 |
| Tax % | -34% | -22% | -31% | -35% | -4% | -25% | -66% | -34% |
| Net Profit | -73 | -6 | 16 | -11 | -4 | -13 | -6 | -12 |
| EPS in Rs | -3.86 | -0.30 | 0.83 | -0.57 | -0.19 | -0.68 | -0.29 | -0.64 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 580 | 600 | 686 | 789 | 773 | 886 | 838 | 869 |
| Expenses | 517 | 534 | 605 | 656 | 738 | 807 | 781 | 819 |
| Operating Profit | 63 | 66 | 80 | 133 | 35 | 80 | 57 | 50 |
| OPM % | 11% | 11% | 12% | 17% | 4.5% | 9% | 7% | 6% |
| Other Income | 21 | 5 | 19 | 29 | 17 | -75 | 17 | 16 |
| Interest | 31 | 36 | 36 | 62 | 62 | 75 | 75 | 69 |
| Depreciation | 11 | 19 | 27 | 33 | 49 | 53 | 54 | 54 |
| Profit before tax | 41 | 15 | 36 | 67 | -60 | -123 | -54 | -56 |
| Tax % | 26% | 45% | 28% | 29% | -14% | -38% | -39% | — |
| Net Profit | 31 | 8 | 26 | 48 | -51 | -76 | -33 | -35 |
| EPS in Rs | 2.26 | 0.58 | 1.47 | 2.70 | -2.73 | -4.06 | -1.72 | -1.80 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 13 | 16 | 16 | 17 | 19 | 19 |
| Reserves | 335 | 365 | 452 | 577 | 626 | 699 | 843 | 910 |
| Borrowings | 313 | 340 | 378 | 461 | 617 | 511 | 428 | 482 |
| Other Liabilities | 120 | 175 | 224 | 293 | 335 | 345 | 338 | 361 |
| Total Liabilities | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,572 | 1,629 | 1,772 |
| Fixed Assets | 82 | 96 | 294 | 304 | 583 | 577 | 569 | 526 |
| CWIP | 68 | 198 | 18 | 207 | 28 | 31 | 9 | 23 |
| Investments | 69 | 74 | 74 | 82 | 82 | 80 | 102 | 217 |
| Other Assets | 562 | 523 | 681 | 753 | 901 | 884 | 949 | 1,007 |
| Total Assets | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,572 | 1,629 | 1,772 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -45 | 74 | 26 | 47 | 19 | 82 | 18 | 44 |
| Cash from Investing Activity | -3 | -66 | -88 | -172 | -115 | -52 | -88 | -30 |
| Cash from Financing Activity | 65 | -26 | 80 | 129 | 78 | -34 | 105 | -13 |
| Net Cash Flow | 17 | -18 | 18 | 3 | -18 | -4 | 35 | 0 |
| Free Cash Flow | -96 | -41 | -13 | -143 | -113 | 41 | -4 | 17 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -124% | 119% | 55% | 60% | 19% | 286% | 24% | 77% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 48.03% | 49.09% | 49.09% | 49.08% | 48.03% | 48.03% | 48.03% | 48.03% |
| FIIs | 0.76% | 1.47% | 2.88% | 2.11% | 2.12% | 0.94% | 0.91% | 0.94% |
| DIIs | 3.38% | 3.83% | 4.14% | 5.48% | 7.77% | 7.70% | 5.42% | 5.33% |
| Public | 47.83% | 45.61% | 43.88% | 43.33% | 42.07% | 43.31% | 45.63% | 45.69% |
| No. of Shareholders | 61,893 | 58,111 | 59,538 | 57,661 | 52,357 | 52,232 | 55,178 | 56,981 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 174 | 204 | 224 | 235 | 243 | 232 | 171 | 207 |
| Inventory Days | 98 | 91 | 127 | 132 | 252 | 210 | 200 | 199 |
| Days Payable | 95 | 125 | 186 | 196 | 248 | 234 | 226 | 258 |
| Cash Conversion Cycle | 177 | 170 | 165 | 171 | 246 | 208 | 145 | 147 |
| Working Capital Days | 78 | 68 | 92 | 102 | 109 | 113 | 94 | 95 |
| ROCE % | 6% | 11% | 7% | 8% | 11% | 0% | 4% | 3% |
Camlin Fine Sciences Ltd
₹1,546Cr.
₹80.4
₹203/78.8
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of CAMLIN FINE SCIENCES LTD (CAMLINFINE)?
The reported market capitalisation for CAMLIN FINE SCIENCES LTD (CAMLINFINE) is ₹1,546Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of CAMLINFINE?
The current price shown for CAMLIN FINE SCIENCES LTD (CAMLINFINE) on Fincrux is ₹80.4 with a 52-week high/low of ₹203/78.8.
What were CAMLINFINE latest quarterly results?
For Jun 2026, CAMLIN FINE SCIENCES LTD (CAMLINFINE) reported sales ₹222 Cr and net profit ₹-12 Cr (figures in ₹ crore unless noted).
What are CAMLINFINE annual sales and net profit?
For TTM, CAMLIN FINE SCIENCES LTD (CAMLINFINE) shows sales of ₹869 Cr and net profit of ₹-35 Cr on the Fincrux profit & loss statement.
Who owns CAMLIN FINE SCIENCES LTD (CAMLINFINE)?
Latest shareholding for CAMLIN FINE SCIENCES LTD (CAMLINFINE) on Fincrux: Promoters 48.03% (Sep 2026), FIIs 0.94% (Sep 2026), DIIs 5.33% (Sep 2026), Public 45.69% (Sep 2026), No. of Shareholders 56,981% (Sep 2026).
Where can I find CAMLIN FINE SCIENCES LTD (CAMLINFINE) financials?
CAMLIN FINE SCIENCES LTD (CAMLINFINE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show CAMLINFINE balance sheet and cash flow?
Yes. The CAMLIN FINE SCIENCES LTD (CAMLINFINE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.